Wrapping up Q4 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including Insulet ...

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

In 2026, consumer wearables do more. They can flag patterns that may point to real health problems, not just a rough wellness trend.

Parkman Healthcare Partners initiated a 200,000-share stake in Masimo during the fourth quarter. The quarter-end position value rose by $26.01 million as a result. Masimo is not among the fund's top ...

People don't buy consumer wearables just to count steps anymore. They want early warnings, useful health signals, and features they can trust.

DelveInsight's Diabetes Care Devices Market Insights report provides the current and forecast market analysis, individual ...

The diabetes care devices market is largely propelled by the increasing global incidence of diabetes, which is influenced by higher obesity rates, sedentary habits, and an aging population.

Galway will host a national gathering of global technology leaders this April as PorterShed marks 10 years of building an ...

New registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with Type 2 diabetes who aren’t on insulin therapy 1, reinforcing the need to broaden ...

BARCELONA, Spain--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for ...